Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers
NCT00984906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2010-06-08
Summary
The aim of the study is to measure the inspiratory flow that the different patient groups (asthmatic children, adults and elderly, as well as chronic obstructive pulmonary disease (COPD) patients) generate through empty Easyhaler (two versions) and Turbuhaler inhalers. In addition, the handling and acceptability of the inhalers will be compared in asthmatic children.
Conditions
- Asthma
- Pulmonary Disease, Chronic Obstructive
Interventions
- OTHER
-
Empty inhalers
Empty Easyhaler inhalers (type A and type B) and empty Turbohaler inhaler
Sponsors & Collaborators
-
Orion Corporation, Orion Pharma
lead INDUSTRY
Principal Investigators
-
Satu Lähelmä, M.Sc.(Pharm) · Orion Corporation, Orion Pharma
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Finland
- United Kingdom
Study Locations
More Related Trials
-
Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction
NCT01033669 ·Status: COMPLETED
-
Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices
NCT02596009 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Pilot Study on Budesonide/Formoterol
NCT01457716 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients
NCT01385696 ·Status: COMPLETED ·Phase: PHASE3
-
HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172404 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease
NCT01016951 ·Status: TERMINATED ·Phase: PHASE1
-
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
NCT03219866 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)
NCT00837629 ·Status: COMPLETED
-
Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD
NCT03755544 ·Status: COMPLETED
-
An Open Study to Assess the Robustness of the CRC749 Inhaler
NCT02474017 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
NCT01721291 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler
NCT01257048 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD
NCT00419744 ·Status: COMPLETED ·Phase: PHASE3
-
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease
NCT00134979 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler
NCT00868426 ·Status: COMPLETED ·Phase: PHASE1
-
Airway Clearance Study
NCT00379028 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus
NCT01856621 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01069289 ·Status: COMPLETED ·Phase: PHASE3
-
Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01380405 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus
NCT03060044 ·Status: COMPLETED ·Phase: PHASE1
-
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)
NCT03197818 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD
NCT00206167 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01713075 ·Status: COMPLETED
-
Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients
NCT02119234 ·Status: COMPLETED ·Phase: PHASE1
-
PIFR-based Inhalation Therapy in Patients Recovering From AECOPD
NCT04000958 ·Status: UNKNOWN ·Phase: NA